Nuwellis, Inc. stock is down -13.26% since 30 days ago. The next earnings date is Feb 27, 2024. The company has had below-average volume in the last 30 days. Its seasonality going into this month shows a chance of a red month, as 25% of the previous 11 December’s closed higher than November. 0% of analysts rate it a buy.
Nuwellis, Inc. focuses on developing, manufacturing, and commercializing medical devices used in ultrafiltration therapy. Its Aquadex FlexFlow system includes a console, disposable blood set, and catheter. The company sells its products to hospitals and clinics through its direct salesforce in the United States.